M&A Transactions
Apollo Endosurgery / Boston Scientific: The company reached a definitive agreement to be acquired by Boston Scientific for approximately $615 million on November 29, 2022. Apollo Endosurgery, Inc. is a medical technology company focused on the development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity.
Akouos / Eli Lilly: The company was acquired by Eli Lilly (NYS: LLY) for $610 million on December 1, 2022. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing.
Liminatus Pharma / Iris Acquisition Corp: The company reached a definitive agreement to acquire Iris Acquisition through a reverse on November 30, 2022. The company is a developer of pharmaceutical research and development created to engineer cancer treating immune cells.
Focus-X Therapeutics / Full-Life Technologies: The company reached a definitive agreement to be acquired by Full-Life Technologies for an estimated $245 million on November 28, 2022. The company is an operator of a radiopharmaceutical business for the treatment of cancer.
Neogene Therapeutics / AstraZeneca: The company reached a definitive agreement to be acquired by AstraZeneca for $320 million on November 29, 2022. The company is an operator of a biotechnology business intended to develop next-generation, fully personalized engineered T-cell therapies for a broad spectrum of cancers.
Excelsior Integrated Medical Group / Ascend Partners: The company was acquired by Rendr, via its financial sponsor Ascend Partners, through an LBO on November 28, 2022 for an undisclosed amount. The company is an operator of a physician group intended to offer primary healthcare services.
Horizon Therapeutics / Amgen: The company has received bids to be acquired by Amgen, Janssen Global Services, and Sanofi for an undisclosed amount on November 29, 2022. Horizon Therapeutics PLC is a specialty and generic drug manufacturing company.
Mediballoon / Medeologix: The company was acquired by Medeologix for an undisclosed amount on November 28, 2022. The company is a manufacturer of medical equipment based in Union City, California.
MGC Diagnostics / CAIRE: The company reached a definitive agreement to be acquired by CAIRE, a subsidiary of NGK Spark Plug, for an undisclosed amount on November 28, 2022. The company is a designer and manufacturer of non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease.
United Vein & Vascular Centers / Amulet Capital Partners: The company was acquired by Amulet Capital Partners through an LBO on November 29, 2022 for an undisclosed amount. The company is an operator of vein and vascular care treatment centers intended to provide innovative vascular health care.
Source: Pitchbook Data, Inc.
|